Repligen (RGEN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $178.19 +3.05%
Revenue Growth %: +9.4%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +9.4%
Financial Fact:
(Loss) income from operations: 3.75M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.11, $0.03 better than the analyst estimate of $0.08. Revenue for the quarter came in at $21.5 million versus the consensus estimate of $20.05 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Astrana Health (ASTH) Mentioned as short at Glass House
- Investec Double Upgrades Supreme Industries (SI:IN) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
